
SLU-PP-332
SLU-PP-332 has been studied only in cells and mice, mostly by the group that developed it. In mice given injections twice a day, it lengthened treadmill running, limited fat gain on a high-fat diet, and protected the heart and the aging kidney in disease models. It has never been given to people in a published study, so there are no human benefits, safety data or doses. Its developers report it is not absorbed well by mouth. It is not FDA-approved.
Research compound: not an approved drug or dietary supplement
This compound is sold for research and is not FDA-approved for human use or as a dietary supplement. Human evidence is limited; purity and dosing of consumer products are unverified. The data below is an evidence review for education only. Talk to a clinician before considering it.
Quick decision guide
May help most
No approved or proven use; laboratory research only
Common dosing range
No approved or established dose for people. Mouse studies injected 50 mg per kg into the abdomen twice daily
When to expect effects
Not established in people
Watch out for
Not FDA-approved and never tested in people, so its safety is unknown; its developers report it lacks oral bioavailability; products sold online have no FDA review of identity, purity or dose; anti-doping laboratories have developed tests for it
What is it
SLU-PP-332 is a lab-made research compound, not an approved drug or a dietary supplement: it is not FDA-approved for any use, and on November 19, 2026 we found no published study in people on PubMed and no registered trial on ClinicalTrials.gov. Chemically it is (E)-4-hydroxy-N'-(naphthalen-2-ylmethylene)benzohydrazide, a small molecule made by researchers at Saint Louis University and colleagues to switch on the estrogen-related receptors (ERR alpha, beta and gamma). Despite the name, these are not estrogen receptors: they are "orphan" receptors inside cells that control genes for energy production in mitochondria. Because it set off exercise-like gene changes and longer running in mice, it is called an "exercise mimetic". Its developers later reported that SLU-PP-332 lacks oral bioavailability and made a different compound, SLU-PP-915, that works by mouth in mice. Several of the developers declare stock in companies developing ERR-based medicines (Myonid Therapeutics and Pelagos Pharmaceuticals). Anti-doping laboratories in the US and Germany published methods in 2026 to detect it and its breakdown products.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
exercise endurance and body fat in mice Mixed Evidence | About 70% longer running time and 12% lower body weight than untreated mice | None in people | Days to 4 weeks in mice |
heart failure and kidney aging in mice Mixed Evidence | Better heart pumping and survival in mice with heart failure; less albuminuria in old mice | None in people | Weeks in mice |
exercise endurance and body fat in mice
- Effect
- About 70% longer running time and 12% lower body weight than untreated mice
- Best fit
- None in people
- Time
- Days to 4 weeks in mice
heart failure and kidney aging in mice
- Effect
- Better heart pumping and survival in mice with heart failure; less albuminuria in old mice
- Best fit
- None in people
- Time
- Weeks in mice
Evidence for 2 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
exercise endurance and body fat in mice
Mechanism onlyIn mice, SLU-PP-332 injected into the abdomen (50 mg per kg twice daily) increased oxidative muscle fibers, and in a treadmill test treated mice ran about 70% longer and about 45% farther than untreated mice; grip strength rose after 2 weeks. In obese mice kept on a high-fat diet, 28 days of the same injections left them about 12% lighter than untreated mice, and they gained less than 0.5 g of fat compared with about 5 g in untreated mice, with no change in food intake or lean mass. In muscle cells taken from 10 inactive women during hip surgery and grown in a dish, SLU-PP-332 raised markers of mitochondrial activity and reduced markers of oxidative stress and cell aging. These are animal and cell results and have never been tested in people. The developers declare stock in companies developing ERR-based medicines.
Bottom line: SLU-PP-332 made injected mice run longer and gain less fat, but it has never been tested in people.
heart failure and kidney aging in mice
Mechanism onlyIn mice with heart failure caused by surgically narrowing the aorta (pressure overload), SLU-PP-332 and a related compound, SLU-PP-915, improved the heart's pumping (ejection fraction), reduced scarring (fibrosis) and increased survival, without changing heart muscle thickening; the effect worked mainly through ERR gamma. In 21-month-old mice, 8 weeks of SLU-PP-332 reversed age-related increases in protein in the urine (albuminuria), loss of kidney filter cells (podocytes), mitochondrial dysfunction and inflammatory signals. These are mouse results and have not been tested in people with heart or kidney disease.
Bottom line: Mouse heart and kidney results are early laboratory findings, not evidence of benefit in people.
How it works
How to take it
What to track
Bottom line: No human dose exists, and nothing sold under this name has been tested in people.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
No human safety data. We found no published human study and no registered trial on November 19, 2026. A 2026 systematic review of the research on SLU-PP-332 and SLU-PP-915 included only animal and cell studies and concluded that clinical trials are needed to confirm their efficacy and safety in humans. Effects on heart rhythm, liver, kidneys, hormones, pregnancy and cancer risk in people are unknown.
Unknown breakdown products and unverified products. In lab tests with human liver preparations, SLU-PP-332 was converted into 9 metabolites in one study and 22 in another; what they do in the body is unknown. Products sold under this name are not FDA-approved, so their identity, purity and dose have not been reviewed.
Doses by mouth may not match the studies. The developers state that SLU-PP-332 lacks oral bioavailability; all of the reported mouse effects came from injections into the abdomen.
Who should avoid it
- Anyone outside laboratory research: the compound has never been tested in people
- Athletes tested under anti-doping rules: the UCLA anti-doping laboratory notes that WADA prohibits exercise mimetics and metabolic modulators, and laboratories in the US and Germany have published detection methods
Pregnancy & breastfeeding
There are no human data on SLU-PP-332 in pregnancy, breastfeeding or fertility, and the 2026 systematic review found only animal and cell studies of other outcomes. Avoid use if you are pregnant, breastfeeding or planning a pregnancy, and talk to your doctor.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Is SLU-PP-332 FDA-approved?⌄
No. SLU-PP-332 is an experimental lab compound. It is not approved by FDA for any use, and it has not completed any of the safety testing an approved medicine goes through.
Has SLU-PP-332 been tested in people?⌄
No. On November 19, 2026 we found no published human study on PubMed and no registered trial on ClinicalTrials.gov. The closest work used muscle cells from 10 women grown in a dish. A 2026 systematic review found only animal and cell studies and said clinical trials are needed.
Is it really "exercise in a pill"?⌄
Only in mice. Mice given injections of SLU-PP-332 ran about 70% longer on a treadmill, and obese mice gained less fat. Mouse results often do not carry over to people, and no one knows what dose, if any, would do this in a person, or what the risks would be. Exercise itself has proven benefits.
Do SLU-PP-332 capsules work by mouth?⌄
That is unknown. Its developers report that SLU-PP-332 lacks oral bioavailability, and all of the mouse results came from injections into the abdomen. They made a different compound, SLU-PP-915, that works by mouth in mice; it has not been tested in people either.
Is SLU-PP-332 banned in sport?⌄
WADA's online Prohibited List search returned no entry named SLU-PP-332 on November 19, 2026. WADA states that its section S0 covers substances not approved by any health authority for human use, including drugs in pre-clinical development, and that a substance missing from the list is not necessarily permitted. The UCLA anti-doping laboratory notes that WADA prohibits exercise mimetics and metabolic modulators, and laboratories have published tests for it. Athletes should check with their anti-doping organization.
Can I take SLU-PP-332 with my supplements or medicines?⌄
No interaction studies exist, and it has never been studied in people. Ask a doctor or pharmacist to review your full list, and tell them if you have used it.
References by claim
exercise endurance and body fat in mice
heart failure and kidney aging in mice
Track SLU-PP-332 with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This compound is not approved by the FDA for human use and is not a dietary supplement. This page is an educational review of available research (much of it preclinical or early-stage), not a recommendation to use it. Consumer product quality is unregulated. Consult a qualified clinician.
